Inovio Pharmaceuticals Inc (INO)’s valuation ratios: A closer look

The closing price of Inovio Pharmaceuticals Inc (NASDAQ: INO) was $0.40 for the day, up 1.28% from the previous closing price of $0.39. In other words, the price has increased by $+0.0050 from its previous closing price. On the day, 2845788 shares were traded. INO stock price reached its highest trading level at $0.4322 during the session, while it also had its lowest trading level at $0.3841.


Our analysis of INO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 3.91. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.07.

The insider

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 05 when Zoth Lota S. sold 5,700 shares for $0.56 per share. The transaction valued at 3,192 led to the insider holds 52,716 shares of the business.

Weiner David B. sold 5,833 shares of INO for $6,708 on Mar 13. The Director now owns 910,124 shares after completing the transaction at $1.15 per share. On Feb 27, another insider, Weiner David B., who serves as the Director of the company, sold 11,668 shares for $1.28 each. As a result, the insider received 14,935 and left with 904,291 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 105.89M and an Enterprise Value of -58.27M. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.01 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at -6.06 whereas that against EBITDA is 0.36.

Stock Price History:

Over the past 52 weeks, INO has reached a high of $2.61, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 0.4206, while the 200-Day Moving Average is calculated to be 0.7443.

Shares Statistics:

INO traded an average of 3.45M shares per day over the past three months and 2.63M shares per day over the past ten days. A total of 268.07M shares are outstanding, with a floating share count of 263.72M. Insiders hold about 1.62% of the company’s shares, while institutions hold 26.94% stake in the company. Shares short for INO as of Oct 12, 2023 were 25.71M with a Short Ratio of 25.71M, compared to 15.63M on Sep 14, 2023. Therefore, it implies a Short% of Shares Outstanding of 9.59% and a Short% of Float of 10.95%.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.00%, it implies a Forward Annual Dividend Yield of 1.52%.

Earnings Estimates

The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.13, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.1 and low estimates of -$0.16.

Analysts are recommending an EPS of between -$0.53 and -$0.58 for the fiscal current year, implying an average EPS of -$0.55. EPS for the following year is -$0.33, with 3 analysts recommending between -$0.21 and -$0.4.

Revenue Estimates

A total of 3 analysts have provided revenue estimates for INO’s current fiscal year. The highest revenue estimate was $800k, while the lowest revenue estimate was $300k, resulting in an average revenue estimate of $580k. In the same quarter a year ago, actual revenue was $10.26M, down -94.30% from the average estimate.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular